Our facility is also National Marrow Donor Program (NMDP) apheresis center.
For emergency care before and after regular office hours, please call (208) 327-8055 to reach the St. Luke's Cancer Institute doctor on call. Please reserve after-hours calls for urgent needs. If you haven’t received a return call from the doctor within 30 minutes, please phone again.
Blog Post
Blog Post
Blog Post
Finn Petersen, MD became involved in the first bone marrow transplants (BMT) in Denmark while in medical school, and after medical school orchestrated the first BMT done for acute leukemia in Denmark. After his fellowship, he joined the faculty at the Fred Hutchinson Cancer Research Center in Seattle and rose to the rank of assistant professor. Afterward, Dr. Petersen accepted a position as full professor at the University of Utah. While there he served as medical director and later program director of the Blood and Marrow Transplant Program, which encompassed the University of Utah's and Intermountain Healthcare's adult BMT programs as well as a pediatric BMT program at Primary Children's Medical Center. He later consolidated adult BMT at the Intermountain Healthcare's LDS Hospital, developing an integrated BMT and hematological malignancy program (blood cancer), focusing on acute leukemia care. In 2015, Dr. Petersen was named one of Utah's Health Care Heroes for his work in establishing and growing a hematological malignancy center of excellence within Intermountain Healthcare.
Dr. Petersen is currently working to develop and lead an allogenic (donor) blood and marrow transplant program at St. Luke's Mountain States Tumor Institute as part of our new "heme-malignancy" (blood cancer) program.
Dr. Petersen is internationally known for his long-standing work focusing on complications related to hematopoietic stem cell transplantation, and is an author and co-author of over 180 peer reviewed scientific publications, books, or book chapters. He is a frequent invited speaker at national and international conferences on topics of infections and treatment-related complications in blood and marrow transplantation and acute leukemia treatment.
Travis G. Williams, DO has a special interest in malignant hematology. During his residency, he researched, presented, and published articles on donor-transmitted non-leukemic promyelocytic sarcoma, acute myeloid leukemia, metastatic papillary renal cell carcinoma, and cancer medicine rate of complete diagnostic testing. He also earned Chief Fellow and Resident of the Year awards.
Dr. Williams earned his bachelor's degree in biology from Idaho State University. He is a member of the American College of Physicians, the American Society of Clinical Oncology, and the American Society of Hematology. He currently chairs a team of IT experts and serves as the St. Luke's Cancer Institute IT Medical Director. In his free time, Dr. Williams enjoys the outdoors and spending time with his family.
Call us to make an appointment.
Call us to make an appointment.
Call us to make an appointment.
Call us to make an appointment.
Call us to make an appointment.
Call us to make an appointment.
Call us to make an appointment.
Call us to make an appointment.
Extracorporeal photopheresis is a type of treatment that can be used for patients with problems associated with cutaneous T-cell lymphoma.
Plasma exchange removes plasma from a patient's blood and replaces it with donor plasma before it is returned to the body.
Article
Article
Article